Invicta Diagnostic IPO KPI Information
The Invicta Diagnostic IPO KPI (Key Performance Indicators) provide valuable insights into the company's financial efficiency, profitability, and capital utilization. Key metrics such as Return on Equity (ROE), Return on Capital Employed (ROCE), Debt-to-Equity Ratio, Return on Net Worth (RoNW), Price-to-Book Value (P/BV), and PAT Margin help investors evaluate the company's operational performance and financial health before investing in the IPO.
Based on the latest reported financial year (Mar 2025), Invicta Diagnostic Limited reported ROE of 44.28%, ROCE of 42%, RoNW of 36.25%, PAT Margin of 16.38%, and Debt-to-Equity Ratio of 0.26. These key financial ratios provide investors with a snapshot of the company's profitability, capital efficiency, leverage, and overall financial strength.
Invicta Diagnostic IPO Key Performance Indicators
- Return on Equity (ROE): 44.28%
- Return on Capital Employed (ROCE): 42%
- Return on Net Worth (RoNW): 36.25%
- PAT Margin: 16.38%
- Debt-to-Equity Ratio: 0.26
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Invicta Diagnostic Limited KPI Information
| Particular | Mar 2025 | Mar 2024 |
|---|---|---|
| ROE % | 44.28 | 55.53 |
| ROCE % | 42 | 56.04 |
| Debt / Equity | 0.26 | 0.44 |
| RoNW % | 36.25 | 43.9 |
| Pat Margin % | 16.38 | 24.04 |
Return Ratio
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Market Cap of Invicta Diagnostic Limited ?
The post-IPO market capitalisation (market cap) of Invicta Diagnostic Limited is approximately ₹0 crore, based on the IPO issue price and the company's post-issue equity share capital. Market cap represents the total market value of a company's outstanding shares and is widely used by investors to assess the company's size and valuation.
What is the ROE of Invicta Diagnostic Limited ?
Invicta Diagnostic Limited reported a Return on Equity (ROE) of 44.28% as of Mar 2025. ROE measures how efficiently the company generates profits from shareholders' equity. A higher ROE generally indicates strong financial performance and effective management of shareholder funds.
What is the ROCE of Invicta Diagnostic Limited ?
The Return on Capital Employed (ROCE) of Invicta Diagnostic Limited stood at 42% as of Mar 2025. ROCE measures how efficiently the company uses its total capital to generate profits. A higher ROCE indicates better capital efficiency and operational performance.
What is the Net Profit Margin (PAT Margin) of Invicta Diagnostic Limited ?
Invicta Diagnostic Limited reported a Profit After Tax (PAT) Margin of 16.38% as of Mar 2025. PAT Margin shows the percentage of revenue that remains as net profit after all operating expenses, interest, and taxes. A higher margin reflects better profitability and cost management.
What is the Return on Net Worth (RoNW) of Invicta Diagnostic Limited ?
The Return on Net Worth (RoNW) of Invicta Diagnostic Limited was 36.25% as of Mar 2025. RoNW measures the company's ability to generate profits from shareholders' net worth and is an important indicator of overall financial efficiency.